Cargando…

Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda

BACKGROUND: In 2018, Uganda started only 65% of persons with incident tuberculosis on treatment. Pretreatment loss to follow up is an important contributor to suboptimal treatment coverage. We aimed to describe the patient and health facility-level characteristics associated with pretreatment loss t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zawedde-Muyanja, Stella, Katamba, Achilles, Cattamanchi, Adithya, Castelnuovo, Barbara, Manabe, Yukari C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713043/ https://www.ncbi.nlm.nih.gov/pubmed/33272226 http://dx.doi.org/10.1186/s12889-020-09955-0

Ejemplares similares

Feasibility of a multifaceted intervention to improve treatment initiation among patients diagnosed with TB using Xpert MTB/RIF testing in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2022)

Patient and health system level barriers to and facilitators for tuberculosis treatment initiation in Uganda: a qualitative study
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2022)

Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2020)

Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis
por: Hanrahan, Colleen F., et al.
Publicado: (2016)

Xpert(®) MTB/RIF associated with improved treatment initiation among patients with smear-negative tuberculosis
por: Zawedde-Muyanja, S., et al.
Publicado: (2018)

Population-Level Impact of Same-Day Microscopy and Xpert MTB/RIF for Tuberculosis Diagnosis in Africa
por: Dowdy, David W., et al.
Publicado: (2013)

Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda
por: Meyer, Amanda J., et al.
Publicado: (2017)

Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses
por: Kendall, Emily A., et al.
Publicado: (2019)

Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective
por: Nalugwa, Talemwa, et al.
Publicado: (2020)

Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up
por: Farr, Katherine, et al.
Publicado: (2019)

Impact of Xpert MTB/RIF Testing on Tuberculosis Management and Outcomes in Hospitalized Patients in Uganda
por: Yoon, Christina, et al.
Publicado: (2012)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

Feasibility and Sensitivity of Saliva GeneXpert MTB/RIF Ultra for Tuberculosis Diagnosis in Adults in Uganda
por: Byanyima, Patrick, et al.
Publicado: (2022)

The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda
por: Andama, A., et al.
Publicado: (2021)

Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda
por: Walusimbi, Simon, et al.
Publicado: (2016)

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study
por: Namugenyi, Juliet, et al.
Publicado: (2021)

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)

Investigation of OMNIgene·SPUTUM performance in delayed tuberculosis testing by smear, culture, and Xpert MTB/RIF assays in Uganda
por: Kelly-Cirino, C.D., et al.
Publicado: (2017)

Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out
por: Muttamba, Winters, et al.
Publicado: (2018)

Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013)

The Role of Xpert MTB/RIF Ultra in Diagnosing Pulmonary Tuberculosis in Children
por: Schaaf, H. Simon, et al.
Publicado: (2019)

Role of GeneXpert MTB/Rif Assay in Diagnosing Tuberculosis in Pregnancy and Puerperium
por: Habib, Zaiyad G., et al.
Publicado: (2015)

The role of Xpert MTB/RIF in diagnosing pulmonary tuberculosis in post-mortem tissues
por: García-Basteiro, Alberto L., et al.
Publicado: (2016)

Combination of Xpert MTB/RIF and MTBDRplus for Diagnosing Tuberculosis in a Chinese District
por: Lv, Chunfang, et al.
Publicado: (2020)

Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
por: Li, Hou-He, et al.
Publicado: (2020)

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
por: Singh, Urvashi B., et al.
Publicado: (2023)

Comparison of Analytical Sensitivity (Limit of Detection) of Xpert MTB/RIF and Xpert MTB/RIF Ultra for Non-Sputum Specimens
por: Nielsen, Marisa C., et al.
Publicado: (2023)

Pooled analysis of the Xpert MTB/RIF assay for diagnosing tuberculous meningitis
por: Chen, Yuan-Zhi, et al.
Publicado: (2020)

Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis
por: Haraka, Frederick, et al.
Publicado: (2021)

Variation in the observed effect of Xpert MTB/RIF testing for tuberculosis on mortality: A systematic review and analysis of trial design considerations
por: Ochodo, Eleanor A., et al.
Publicado: (2020)

Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
por: Kohli, Mikashmi, et al.
Publicado: (2018)

Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis
por: Antel, Katherine, et al.
Publicado: (2020)

Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert® MTB/RIF era: a cohort study
por: Hermans, Sabine M., et al.
Publicado: (2017)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study
por: Donovan, Joseph, et al.
Publicado: (2020)

Pooling sputum testing to diagnose tuberculosis using xpert MTB/RIF and xpert ultra: a cost-effectiveness analysis
por: Iem, Vibol, et al.
Publicado: (2023)

Which sample type is better for Xpert MTB/RIF to diagnose adult and pediatric pulmonary tuberculosis?
por: Lyu, Mengyuan, et al.
Publicado: (2020)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

Evaluation of Xpert(®) MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1pnsvffmrp0kd8c0ifum5ptkho